Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 30, 2023 |
Apr. 30, 2022 |
| Income Statement [Abstract] |
|
|
| Revenue |
$ 99,453
|
$ 98,802
|
| Cost of revenue |
21,350
|
24,728
|
| Gross profit |
78,103
|
74,074
|
| Operating expenses: |
|
|
| Sales and marketing |
43,996
|
60,779
|
| Research and development |
16,753
|
17,302
|
| General and administrative |
18,586
|
21,495
|
| Total operating expenses |
79,335
|
99,576
|
| Loss from operations |
(1,232)
|
(25,502)
|
| Interest income |
1,534
|
25
|
| Interest expense |
(73)
|
(143)
|
| Other (expense) income, net |
(320)
|
129
|
| Loss from operations before income taxes |
(91)
|
(25,491)
|
| (Provision for) benefit from income taxes |
(321)
|
(348)
|
| Net loss |
$ (412)
|
$ (25,839)
|
| Net loss per share attributable to common stockholders, basic (in dollars per share) |
$ 0
|
$ (0.20)
|
| Net loss per share attributable to common stockholders, diluted (in dollars per share) |
$ 0
|
$ (0.20)
|
| Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic (in shares) |
123,266,684
|
131,144,055
|
| Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted (in shares) |
123,266,684
|
131,144,055
|
| Other comprehensive income (loss): |
|
|
| Foreign currency translation adjustment |
$ 350
|
$ (3,414)
|
| Unrealized loss on marketable securities, net |
(4)
|
0
|
| Total comprehensive loss |
$ (66)
|
$ (29,253)
|